biomedicina slovenica


pr=Bonde : 13

  1. Vink Frederique J.; Meijer Chris J.L.M.; Hesselink Albertus; Floore Arno N.; Lissenberg-Witte Birgit I.; Bonde Jesper; Pedersen Helle; Cuschieri Kate S.; Poljak Mario; Oštrbenk Valenčak Anja
    FAM19A4/miR124-2 methylation testing and HPV16/18 genotyping in HPV-positive women under the age of 30 years
    2022
  2. Arbyn Marc; Bonde Jesper; Cushieri Kate; Poljak Mario
    Can HPV Selfy be considered as a clinically validated HPV test for use in cervical cancer screening?
    2022
  3. Heideman Daniëlle A. M.; Oštrbenk Valenčak Anja; Doorn Saskia; Bonde Jesper; Hillemanns Peter; Gimpelj Domjanič Grega; Mlakar Jana; Hesselink Albertus; Meijer Chris J.L.M.; Poljak Mario
    Clinical validation of the fully automated NeuMoDx HPV assay for cervical cancer screening
    2022
  4. Bonde Jesper; Floore Arno; Ejegod Ditte; Vink Frederique J.; Hesselink Albertus; Van der Ven Peter F. M.; Oštrbenk Valenčak Anja; Pedersen Helle; Doorn Saskia; Poljak Mario
    Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women
    2021
  5. Vink Frederique J.; Dick Stèfanie; Heideman Daniëlle A. M.; De Strooper Lise M. A.; Steenbergen Renske D. M.; Lissenberg-Witte Birgit I.; Floore Arno; Bonde Jesper; Oštrbenk Valenčak Anja; Poljak Mario
    Classification of high-grade cervical intraepithelial neoplasia by p16 ink4a , Ki-67, HPV E4 and FAM19A4/miR124-2 methylation status demonstrates considerable heterogeneity with potential consequences for management
    2021
  6. Arbyn Marc; Simon Marie; Peeters Eliana; Xu Lan; Meijer Chris J.L.M.; Berkhof Johannes; Cuschieri Kate S.; Bonde Jesper; Oštrbenk Valenčak Anja; Poljak Mario
    2020 list of human papillomavirus assays suitable for primary cervical cancer screening
    2021
  7. Meijer C. J. L. M.; Hesselink B.; Heideman D. A. M.; Petry K. U.; Poljak Mario; Bonde J.; Cuschieri Kate S.; Del Pino M; Quint Wim; Floore A.
    Surveillance of young HPV-positive women below age of 30 by FAM19A4/MIR124 methylation
    2020
  8. Xu Lan; Benoy Ina; Cuschieri Kate S.; Poljak Mario; Bonde Jesper; Arbyn Marc
    Accuracy of genotyping for HPV16 and 18 to triage women with low-grade squamous intraepithelial lesions
    2019
  9. Hesselink B.; Petry Karl Ulrich; Cuschieri Kate S.; Bonde J.; Del Pino M; Quint Wim; Poljak Mario; Meijer C. J. L. M.; Floore A.; Heideman D. A. M.
    Surveillance of young HPV-positive women below age of 30 by FAM19A4/miR124methylation
    2019
  10. Vink Frederique J.; Meijer Chris J.L.M.; Clifford Gary M.; Poljak Mario; Oštrbenk Valenčak Anja; Petry Karl Ulrich; Rothe Beate; Bonde Jesper; Pedersen Helle; de Sanjosé Silvia
    FAM19A4/miR124-2 methylation in invasive cervical cancer
    2019
  11. Floore A.; Hesselink B.; Bonde J.; Poljak Mario
    Inter-laboratory agreement of the FAM19A4/miR124 - 2 methylation test - a valid-screen (H2020) sub-study
    2017
  12. Abryn M.; Poljak Mario; Mejjer C.; Cuschieri Kate S.; Heard Isabelle; Bogers Johannes; Bonde J.; Tommasino M.; Ifner T.; Sasieni P.
    Update of the list of HPV assays that fulfill requirements for primary cervical cancer screening
    2017
  13. Bangsbo J; Saltin B; Bonde H; Hellsten Y; Ibsen B; Kjaer M; Sjogaard G
    Sport science in a changing world of sports. Book of abstracts 1 of the 2nd annual congress of the European college of sports science: oral presentations; 1997 Aug 20-23; Copenhagen
    1997


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics